Fig. 3.

Results of the EORTC QLQ-C30 quality-of-life questionnaire and its brain-specific module (BN20). Results are presented at baseline, end of treatment, and each follow-up for the first 2 years for all patients who had not developed tumor progression at each time point. All results are presented as mean ± SEM. (A) Overall quality score. A higher score indicates improved QoL. (B) Multisystem score on the BN20 module. Lower score indicates improved QoL. (C) Single-system score on the BN20 module. Lower score indicates improved QoL.